|
WO1988009330A1
(en)
*
|
1987-05-20 |
1988-12-01 |
Zambon Group S.P.A. |
Isoxazoles with nootropic activity
|
|
CA1323301C
(en)
|
1987-06-05 |
1993-10-19 |
Alan I. Faden |
Thyrotropin-releasing hormone analogs in cns injury
|
|
FR2622581B1
(fr)
*
|
1987-11-03 |
1990-02-16 |
Inorgan Sa Rech Develop Pharm |
Nouveaux derives de l-proline, leur preparation et leurs applications biologiques
|
|
HU904967D0
(en)
*
|
1988-04-22 |
1991-01-28 |
Hoechst Ag |
Process for producing new azabicyclo(3.3.o)octane-3-carboxylic acid-octylesther derivatives
|
|
DE4007869A1
(de)
|
1990-03-13 |
1991-09-19 |
Merck Patent Gmbh |
Aminosaeurederivate
|
|
JPH045240A
(ja)
|
1990-04-20 |
1992-01-09 |
Taisho Pharmaceut Co Ltd |
抗痴呆剤
|
|
CA2098609A1
(en)
|
1990-12-28 |
1992-06-29 |
Raymond T. Bartus |
Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
|
|
WO1992013549A1
(en)
*
|
1991-02-07 |
1992-08-20 |
Research Corporation Technologies, Inc. |
Inhibition of cell proliferation by hydrophobic peptides
|
|
US6235929B1
(en)
|
1991-12-27 |
2001-05-22 |
Georgia Tech Research Corporation |
Tripeptide α-ketoamides
|
|
US5716929A
(en)
|
1994-06-17 |
1998-02-10 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of interleukin-1β converting enzyme
|
|
US5834029A
(en)
|
1994-07-20 |
1998-11-10 |
Cytotherapeutics, Inc. |
Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
|
|
WO1996041638A1
(en)
|
1995-06-13 |
1996-12-27 |
Sanofi Winthrop, Inc. |
Calpain inhibitors for the treatment of neurodegenerative diseases
|
|
US5840838A
(en)
*
|
1996-02-29 |
1998-11-24 |
University Of Kentucky Research Foundation |
Process for enhancing the activity of amyloid β peptides
|
|
US6365573B1
(en)
|
1996-10-04 |
2002-04-02 |
Neuronz Ltd. |
Regulation of neural enzymes
|
|
JP4727770B2
(ja)
*
|
1997-09-26 |
2011-07-20 |
カルピス株式会社 |
尿中カテコールアミン低下、尿中ノルアドレナリン低下、尿中ドーパミン低下及びＦｉｓｃｈｅｒ比低下の少なくとも１つの軽減剤
|
|
US6080848A
(en)
*
|
1998-05-01 |
2000-06-27 |
Incyte Pharmaceuticals, Inc. |
Human brain associated protein
|
|
US6379691B1
(en)
*
|
1998-09-29 |
2002-04-30 |
Medtronic/Ave, Inc. |
Uses for medical devices having a lubricious, nitric oxide-releasing coating
|
|
AU1574701A
(en)
*
|
1999-10-22 |
2001-04-30 |
Wrair Walter Reed Army Institute Of Research |
A pharmaceutical composition containing pglu-glu-pro-nh2 and method for treating diseases and injuries to the brain, spinal cord and retina using same
|
|
JP4633876B2
(ja)
*
|
1999-11-11 |
2011-02-16 |
カルピス株式会社 |
トリペプチドの製造方法
|
|
WO2001068114A1
(en)
|
2000-03-10 |
2001-09-20 |
Monsanto Company |
Novel peptides with anti-hypertensive activity
|
|
DE10105041A1
(de)
*
|
2001-02-05 |
2002-08-14 |
Tell Pharm Ag Hergiswil |
Tripeptide und Tripeptid-Derivate für die Behandlung neurodegenerativer Krankheiten
|
|
DE10105038B4
(de)
*
|
2001-02-05 |
2005-07-07 |
Neurotell Ag |
Tripeptid-Derivate für die Behandlung von postläsionalen Krankheiten des Nervensystems
|